Abstract:Abstract BackgroundBreast cancer (BC) patients were threatened by distant metastasis and drug resistance for a long time. The mechanism was to be explored urgently. Proteasome 26S subunit non-ATPase 8 (PSMD8) was associated with protein degradation, but little was known about its role in BC.MethodsThe bioinformatics analysis was obtained from public databases. Breast cancer cell lines were knocked down or overexpressed PSMD8/kinesin family member 10 (KIF10) and detected their ability of proliferation and invasion. epithelial-to-mesenchymal transition (EMT)-related markers were detected by the western blot and immunohistochemistry. In vivo models were established to verify the effect of PSMD8 on tumor growth and distant metastasis. Cells were exposed to paclitaxel (PTX) and examined their apoptosis by flow cytometry.ResultsIn the present study, we defined PSMD8 as a tumor-promoting molecule. PSMD8 was abnormally upregulated in BC tissues compared with adjacent tissues. High PSMD8 expression was related to poor prognosis in BC patients. The knockdown of PSMD8 attenuated the biological effect and epithelial-mesenchymal transition (EMT) progression in vitro and in vivo, and the overexpression of PSMD8 increased tumor progression in vitro. Furthermore, PSMD8 knockdown dramatically augmented the sensitivity of BC cells to paclitaxel, whereas PSMD8 overexpression showed the opposite effects. Mechanistic analysis indicated that PSMD8 activated the expression of kinesin family member 10 (KIF10) and its downstream extracellular regulated MAP kinase (ERK) signaling. Similar to PSMD8, we revealed that the expression of KIF10, which showed a positive correlation with PSMD8, was increased in BC tissues compared with adjacent tissues and associated with a poor prognosis of BC patients. The KIF10 knockdown significantly antagonized the facilitating effect of PSMD8 on the EMT program and chemotherapy tolerance. Finally, knocking down the level of KIF10 or inhibiting the ERK pathway in PSMD8-overexpressing cell lines partially blocked EMT progression and resistance against paclitaxel (PTX). ConclusionsIn conclusion, our results demonstrated that the PSMD8/KIF10 axis promoted BC development and PTX resistance via the ERK pathway. Our findings provide a theoretical basis for targeting PSMD8 to BC cells as a novel target for the treatment of BC.

Deubiquitinating enzyme PSMD7 promotes bladder cancer development: Involvement of RAB1A stabilization

BRD7 Suppresses Tumor Chemosensitivity to CHK1 Inhibitors by Inhibiting USP1-mediated Deubiquitination of CHK1

Depletion of the Proteasome Subunit Psma7 Inhibits Colorectal Cancer Cell Tumorigenicity and Migration

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4

Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway

DHCR7 Promotes Tumorigenesis Via Activating PI3K/AKT/mTOR Signalling Pathway in Bladder Cancer

Deubiquitinase PSMD14 promotes tumorigenicity of glioblastoma by deubiquitinating and stabilizing β‐catenin

PSMD8 Promotes Breast Cancer Progression and Attenuates Paclitaxel Sensitivity by Regulating the Expression of KIF10

PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.

Ubiquitin-specific Protease 7 Sustains DNA Damage Response and Promotes Cervical Carcinogenesis.

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT

Aberrant FBXW7-mediated Ubiquitination and Degradation of ZMYND8 Enhances Tumor Progression and Stemness in Bladder Cancer.

USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability

Inhibition of the Deubiquitinase USP9x Induces Pre-B Cell Homeobox 1 (PBX1) Degradation and Thereby Stimulates Prostate Cancer Cell Apoptosis

Deubiquitinase OTUD7B regulates cell proliferation in breast cancer

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression